Sen. Grassley on importation
Executive Summary
Sen. Chuck Grassley (R-Iowa) expresses optimism that a drug importation bill will pass Senate in 2004. The result may be "a little less money for research for our pharmaceuticals, but why wouldn't we expect [manufacturers] to sell their drugs a little bit higher to German or Canadian consumers?" he asks during the Joint National Government Affairs Advertising Conference in Washington, D.C. April 28. Senate Health Committee plans to hold hearings on importation in May (1"The Pink Sheet" April 26, 2004, p. 19)...
You may also be interested in...
Senate Drug Import Bill Would Require Notice Of Manufacturing Changes
Drug manufacturers would be required to notify FDA of any manufacturing changes that might serve to circumvent reimportation under bipartisan legislation introduced by Sens. Byron Dorgan (D-N.D.) and Edward Kennedy (D-Mass.) April 21
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.